Return to Vaccination News Home Page __» Right-click to "open in new window"
Subscribe to the Vaccination NewsLetter
View past & current Scandals (columns by Sandy Mintz)
Search This Site using keywords
![]() |
July 2003 • Volume 37 • Number 7
|
Infectious Diseases |
Only Hib is somewhat precarious
For
the First Time in Several Years, CDC Deems Vaccine Supply to Be Stable
Joyce Frieden
Associate Editor, Practice Trends
WASHINGTON — Dean Mason is a happy man.
“For the first time in a long time, we can say that the vaccine supply is okay,”
said Mr. Mason, program support branch chief at the Centers for Disease Control
and Prevention's National Immunization Program Immunization Services Division.
Take the supply of DTaP vaccine, for example. “We are awash in DTaP vaccine,”
Mr. Mason said at a meeting of the CDC's National Vaccine Advisory Committee.
Supplies of MMR vaccine are good too: CDC had a goal of stockpiling 4 million
doses and currently has 3.5 million doses stockpiled, with another 549,000
purchased and awaiting delivery. Supplies also are good for varicella and
pneumococcal vaccines.
But there is one vaccine that he is a little worried about. “Hib [Haemophilus
influenza b] is the vaccine we'll most closely need to monitor,” he said. The
reason is that Wyeth, one of three manufacturers, has had some supply problems.
“Their Hib supply for the last 6 months of 2002 was almost nonexistent,” Mr.
Mason said. “[Two other manufacturers] were able to supply it in sufficient
quantities to make up, but Wyeth must begin supplying by September 2003” or the
stockpile will fall behind. In conversations with CDC officials, the company has
said it's committed to resuming its Hib supply, he added.
Even with the good news about supply, the CDC is not resting on its laurels.
Instead, the agency has hired an outside contractor, the Logistics Management
Institute (LMI), to develop a strategic plan for keeping up the stockpile. LMI
has been asked to submit a plan to the National Immunization Program by the end
of this month.
Although the supply is stable, problems with distributing vaccines under the
Vaccines for Children (VFC) program still persist, Mr. Mason said, noting that
VFC representatives have documented the problems in site visits to physician
offices. “There are significant issues with vaccine storage at inadequate
temperatures and with rotating stock,” he said. “It troubles me that vaccines
are sitting in the [physician's] fridge that are expired.”
Another problem is that some physicians are giving VFC vaccines to privately
insured children and then billing for the vaccinations as if they had paid for
the vaccines themselves. That makes Mr. Mason wonder whether doctors should be
required to keep track of the vaccine they get from the program.
| Copyright © 2003 by International Medical News Group, an Elsevier company. Click for restrictions. |
Return to Vaccination News Home Page __» Right-click to "open in new window"
DISCLAIMER: All information, data, and material contained, presented, or provided here is for general information purposes only and is not to be construed as reflecting the knowledge or opinions of the publisher, and is not to be construed or intended as providing medical or legal advice. The decision whether or not to vaccinate is an important and complex issue and should be made by you, and you alone, in consultation with your health care provider.